Clinical Data Posts 64 Percent Rise in Fiscal Q2 Revenue as Icoria Ag Line Winds Down and Erases Profits | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data today said fiscal second-quarter 2007 revenues increased 64 percent as R&D spending on vilazodone studies rose 54 percent and profit turned swung to a loss.
 
Total receipts for the three months ended Sept. 30 increased to $19.2 million from $11.7 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.